Xoma Investor Relations Material
Latest events
Status Update
Xoma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Xoma
Access all reports
XOMA Corporation is a biotechnology company focused on licensing and royalty acquisitions related to commercial and late-stage pharmaceutical assets. The company does not develop or market its own products but instead acquires rights to future royalty streams and milestone payments associated with therapeutic candidates developed by other companies. XOMA’s portfolio includes interests in various drug candidates across multiple therapeutic areas. The company is headquartered in Emeryville, California, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
XOM
Country
🇸🇪 Sweden